ICER’s Health Technology Assessments review process is an assessment undertaken by one of three ap...
Read moreGVD is a core document, which may be considered the “heart” of the pharmaceutical product’s pa...
Read moreA multidisciplinary process that uses explicit methods to determine the value of a health technology...
Read moreHow has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...
Read moreThe SMC has recently announced that it is beginning to restart its medicines appraisal process in a ...
Read moreNICE has decided to adapt the technical engagement step in a hope to improve stakeholder inclusion, ...
Read moreWithout a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...
Read moreWe received fabulous feedback, with responses from at least 15 industry executives across global pha...
Read moreWhilst many businesses are currently working remotely, up-skilling your workforce through interactiv...
Read moreCAR T-cell therapies and speculation in the pricing and market access implications for the lymphoma ...
Read more